Sidra Medicine, a member of the Qatar Foundation, has contributed to research identifying the cancer-promoting effects of a rare genetic variant linked to an increased risk of colorectal cancer in Qatar. The study, conducted in collaboration with Hamad Bin Khalifa University (HBKU) and using genomic data from the Qatar Precision Health Institute (QPHI), focused on a variant in the MLH1 gene associated with Lynch syndrome, the most common inherited form of colorectal cancer.
The research examined the MLH1 p.His112Arg variant, initially identified through an analysis of whole-genome sequencing data from 14,392 QPHI participants. Researchers found five individuals carrying the variant, but existing evidence was insufficient to assess whether it increased cancer risk. To address this uncertainty, Sidra Medicine researchers employed CRISPR-Cas9 gene-editing technology to introduce the variant into human colorectal cancer-modified cells and then transplanted these cells into zebrafish larvae. The transparency of zebrafish larvae enabled the team to monitor tumor growth and progression over a relatively short timeframe in a living organism.
The study’s findings, published in the International Journal of Cancer, provide new evidence that the MLH1 p.His112Arg variant has cancer-promoting effects. This advance is significant for hereditary colorectal cancer risk assessment, as DNA mismatch repair gene variants like this one can substantially elevate an individual’s lifetime cancer risk.
Experts involved in the study highlighted the broader implications for hereditary cancer prevention and early detection. Dr. Sahar Isa Da’as from Sidra Medicine noted that genetic databases primarily built from non-regional populations often cannot clarify the significance of variants found in Qatari or regional populations. She described the zebrafish model as a valuable tool that enables rapid functional testing of such variants, reducing the time needed to determine their impact from months to days.
Dr. Amal Elfatih, senior research specialist at QPHI, emphasized the importance of combining population genomics with functional studies to resolve uncertain genetic variants, especially in underrepresented populations. She stated that clarifying the significance of these variants can enhance screening and genetic testing efforts, helping to direct resources to individuals genuinely at risk and supporting earlier cancer detection.
The research was supported by funding from HBKU’s College of Health and Life Sciences and Sidra Medicine’s Research Department. The collaborative study highlights ongoing efforts to improve genetic risk assessments tailored to the genetic diversity of populations in the Gulf region.
